Mark W.M. Schellings

2.8k total citations · 1 hit paper
24 papers, 2.3k citations indexed

About

Mark W.M. Schellings is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Mark W.M. Schellings has authored 24 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Mark W.M. Schellings's work include Cardiac Fibrosis and Remodeling (6 papers), Connective tissue disorders research (5 papers) and Signaling Pathways in Disease (4 papers). Mark W.M. Schellings is often cited by papers focused on Cardiac Fibrosis and Remodeling (6 papers), Connective tissue disorders research (5 papers) and Signaling Pathways in Disease (4 papers). Mark W.M. Schellings collaborates with scholars based in Netherlands, Belgium and United States. Mark W.M. Schellings's co-authors include Stéphane Heymans, Yigal M. Pinto, Davy Vanhoutte, Blanche Schroen, Rudy F. Duisters, Joost J. Leenders, Veronica Hérias, Melissa Swinnen, Ingeborg van der Made and Esther E. Creemers and has published in prestigious journals such as Circulation, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Mark W.M. Schellings

23 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

miR-133 and miR-30 Regulate Connective Tissue Growth Factor

2008 700 citations Rudy F. Duisters, Anke J. Tijsen et al. Circulation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark W.M. Schellings Netherlands	18	1.1k	1.1k	777	363	175	24	2.3k
Alessandro Salvi Italy	27	1.2k 1.0×	976 0.9×	699 0.9×	360 1.0×	148 0.8×	81	2.6k
Dominique PV de Kleijn Netherlands	16	1.6k 1.4×	600 0.6×	805 1.0×	466 1.3×	134 0.8×	24	2.5k
Masashi Arai Japan	33	1.5k 1.3×	1.2k 1.2×	252 0.3×	275 0.8×	234 1.3×	76	2.9k
Junbo Ge China	30	1.3k 1.1×	721 0.7×	573 0.7×	340 0.9×	123 0.7×	128	2.6k
Mirjam B. Smeets Netherlands	18	1.3k 1.2×	474 0.4×	602 0.8×	448 1.2×	156 0.9×	26	2.4k
Loukas Kaklamanis Greece	26	892 0.8×	323 0.3×	564 0.7×	257 0.7×	375 2.1×	76	1.9k
Felix Jansen Germany	25	2.1k 1.8×	945 0.9×	1.2k 1.6×	348 1.0×	99 0.6×	74	3.1k
Rugmani Padmanabhan Iyer United States	25	1.2k 1.1×	1.3k 1.2×	538 0.7×	516 1.4×	538 3.1×	39	2.8k
Marja Hedman Finland	23	1.3k 1.1×	643 0.6×	200 0.3×	640 1.8×	300 1.7×	78	2.4k
Sandra B. Haudek United States	24	1.3k 1.1×	1.2k 1.1×	324 0.4×	466 1.3×	313 1.8×	41	2.8k

Countries citing papers authored by Mark W.M. Schellings

Since Specialization

Citations

This map shows the geographic impact of Mark W.M. Schellings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W.M. Schellings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W.M. Schellings more than expected).

Fields of papers citing papers by Mark W.M. Schellings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W.M. Schellings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W.M. Schellings. The network helps show where Mark W.M. Schellings may publish in the future.

Co-authorship network of co-authors of Mark W.M. Schellings

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W.M. Schellings. A scholar is included among the top collaborators of Mark W.M. Schellings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W.M. Schellings. Mark W.M. Schellings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gammeren, Adriaan J. van, et al.. (2024). Type of D-dimer assay determines the diagnostic yield of computed tomography in patients suspected for pulmonary embolism. Research and Practice in Thrombosis and Haemostasis. 9(1). 102638–102638.

Rienks, Marieke, Paolo Carai, Nicole Bitsch, et al.. (2017). Sema3A promotes the resolution of cardiac inflammation after myocardial infarction. Basic Research in Cardiology. 112(4). 42–42. 69 indexed citations

Schellings, Mark W.M., et al.. (2017). Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist. Clinical Chemistry. 63(9). 1442–1444. 2 indexed citations

Schellings, Mark W.M., et al.. (2016). Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery. Thrombosis Research. 139. 128–134. 31 indexed citations

Kerkhof, Daan van de, et al.. (2016). Interference of anticoagulants on coagulation testing. Clinical Chemistry and Laboratory Medicine (CCLM). 54(7). e207–e210. 3 indexed citations

Dongen, Joost L. J. van, Mark W.M. Schellings, Judith M. A. Emmen, et al.. (2014). Determination of dabigatran, rivaroxaban and apixaban by ultra‐performance liquid chromatography – tandem mass spectrometry (UPLC‐MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants. Journal of Thrombosis and Haemostasis. 12(10). 1636–1646. 144 indexed citations

Schellings, Mark W.M., et al.. (2013). Mast cell count and morphology in the diagnosis of low-grade myelodysplastic syndromes. Journal of Clinical Pathology. 66(12). 1092–1094. 1 indexed citations

Almen, Geert C. van, Wouter Verhesen, Rick E.W. van Leeuwen, et al.. (2011). MicroRNA‐18 and microRNA‐19 regulate CTGF and TSP‐1 expression in age‐related heart failure. Aging Cell. 10(5). 769–779. 212 indexed citations

Verjans, Johan, Mark W.M. Schellings, Dagfinn Løvhaug, et al.. (2010). Early molecular imaging of interstitial changes in patients after myocardial infarction: Comparison with delayed contrast-enhanced magnetic resonance imaging. Journal of Nuclear Cardiology. 17(6). 1065–1072. 33 indexed citations

10.

Schellings, Mark W.M., Davy Vanhoutte, Geert C. van Almen, et al.. (2010). Syndecan-1 Amplifies Angiotensin II–Induced Cardiac Fibrosis. Hypertension. 55(2). 249–256. 63 indexed citations

11.

Laufer, Eduard M., Alma M.A. Mingels, Mark H.M. Winkens, et al.. (2010). The Extent of Coronary Atherosclerosis Is Associated With Increasing Circulating Levels of High Sensitive Cardiac Troponin T. Arteriosclerosis Thrombosis and Vascular Biology. 30(6). 1269–1275. 108 indexed citations

12.

Schellings, Mark W.M., Geert C. van Almen, E. Helene Sage, & Stéphane Heymans. (2009). Thrombospondins in the heart: potential functions in cardiac remodeling. Journal of Cell Communication and Signaling. 3(3-4). 201–213. 41 indexed citations

13.

Schellings, Mark W.M., Davy Vanhoutte, Melissa Swinnen, et al.. (2008). Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. The Journal of Experimental Medicine. 206(1). 113–123. 166 indexed citations

14.

Duisters, Rudy F., Anke J. Tijsen, Blanche Schroen, et al.. (2008). miR-133 and miR-30 Regulate Connective Tissue Growth Factor. Circulation Research. 104(2). 170–178. 700 indexed citations breakdown →

15.

Borst, Martin H. de, Sander H. Diks, Juliane Bolbrinker, et al.. (2007). Profiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage. American Journal of Physiology-Renal Physiology. 293(1). F428–F437. 17 indexed citations

16.

Schroen, Blanche, Joost J. Leenders, A. Bertrand, et al.. (2007). Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy. The Journal of Experimental Medicine. 204(5). 1227–1235. 34 indexed citations

17.

Vanhoutte, Davy, et al.. (2006). 522 Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. European Journal of Heart Failure Supplements. 5(1). 111–111. 3 indexed citations

18.

Vanhoutte, Davy, et al.. (2005). Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window. Cardiovascular Research. 69(3). 604–613. 197 indexed citations

19.

Schellings, Mark W.M.. (2004). Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovascular Research. 64(1). 24–31. 155 indexed citations

20.

Rouwet, Ellen V., Andrei N. Tintu, Mark W.M. Schellings, et al.. (2002). Hypoxia Induces Aortic Hypertrophic Growth, Left Ventricular Dysfunction, and Sympathetic Hyperinnervation of Peripheral Arteries in the Chick Embryo. Circulation. 105(23). 2791–2796. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact